ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Design and synthesis of novel Osimertinib analogs for dual EGFR and P-glycoprotein 1 inhibition targeting multidrug resistance in non-small cell lung cancer: In vitro and in vivo evaluation.

Harikrishna Akkapelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.